Chinese Journal of Antituberculosis ›› 2022, Vol. 44 ›› Issue (12): 1338-1344.doi: 10.19982/j.issn.1000-6621.20220304
• Original Articles • Previous Articles Next Articles
Shi Jiayun, Wang Manzhi, Zhou Haiyi, Zhang Xiaofo, Wei Songqing()
Received:
2022-08-09
Online:
2022-12-10
Published:
2022-12-02
Contact:
Wei Songqing
E-mail:573508606@qq.com
Supported by:
CLC Number:
Shi Jiayun, Wang Manzhi, Zhou Haiyi, Zhang Xiaofo, Wei Songqing. Dynamic changes and significance of biomarkers of cerebral injury in pediatric tuberculous meningitis[J]. Chinese Journal of Antituberculosis, 2022, 44(12): 1338-1344. doi: 10.19982/j.issn.1000-6621.20220304
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20220304
神经组织 标志物 | 结核性脑膜炎组(72例) | 肺结核组 (20例) | Z值a | P值 | ||
---|---|---|---|---|---|---|
完全康复组 (47例) | 预后不良组 (25例) | 合计 | ||||
血清标本 | ||||||
NSE | 13.16(3.22,24.86) | 14.94(8.40,26.90) | 15.12(3.22,26.9) | 7.03(2.48,13.23) | -5.064 | 0.000 |
S100B | 1.03(0.4,2.13) | 1.26(0.40,3.20) | 1.11(0.40,3.20) | 0.25(0.12,0.36) | -6.817 | 0.000 |
GFAP | 13.28(3.44,28.35) | 19.21(6.81,45.82) | 15.34(3.44,45.82) | 10.38(2.41,19.00) | -2.693 | 0.007 |
脑脊液标本 | ||||||
NSE | 29.37(6.50,68.82) | 60.16(24.90,142.70) | 37.90(6.50,142.70) | 7.56(2.12,12.79) | -6.465 | 0.000 |
S100B | 1.97(1.02,6.10) | 2.59(1.32,10.20) | 2.31(1.02,10.20) | 0.35(0.05,0.51) | -6.816 | 0.000 |
GFAP | 45.39(10.87,84.93) | 118.74(58.83,252.60) | 65.31(10.87,252.60) | 7.86(2.41,13.80) | -6.778 | 0.000 |
神经组织标志物 | 完全康复组(47例) | 预后不良组(25例) | Z值 | P值 |
---|---|---|---|---|
NSE | ||||
治疗后1周 | 7.80(3.42,24.83) | 8.53(2.90,34.83) | 3.496 | 0.084 |
治疗后2周 | 7.48(2.29,16.40) | 8.14(2.47,22.67) | 2.614 | 0.116 |
治疗后3周 | 6.64(2.48,13.23) | 7.57(2.30,21.18) | -0.041 | 0.967 |
χ2值 | 2.904 | 1.034 | ||
P值 | 0.085 | 0.079 | ||
S100B | ||||
治疗后1周 | 0.43(0.22,0.95) | 0.51(0.31,1.01) | -0.331 | 0.740 |
治疗后2周 | 0.33(0.11,1.47) | 0.32(0.29,1.13) | -1.745 | 0.081 |
治疗后3周 | 0.34(0.09,0.86) | 0.38(0.05,1.47) | -2.070 | 0.836 |
χ2值 | 1.310 | 0.195 | ||
P值 | 0.193 | 0.202 | ||
GFAP | ||||
治疗后1周 | 14.40(3.44,38.51) | 17.20(9.50,30.63) | -0.940 | 0.347 |
治疗后2周 | 12.86(4.62,28.80) | 13.64(6.83,23.63) | -0.337 | 0.736 |
治疗后3周 | 11.92(4.38,28.80) | 11.49(3.44,26.69) | -0.705 | 0.141 |
χ2值 | 0.632 | 1.690 | ||
P值 | 0.068 | 0.053 |
神经组织标志物 | 完全康复组(47例) | 预后不良组(25例) | Z值 | P值 |
---|---|---|---|---|
NSE | ||||
治疗后1周 | 18.49(4.87,36.12) | 49.58(15.38,87.56) | -2.496 | 0.013 |
治疗后2周 | 14.51(4.87,35.70) | 41.53(9.60,82.00) | -3.815 | 0.000 |
治疗后3周 | 8.53(2.12,21.70) | 25.97(5.56,58.49) | -4.041 | 0.000 |
χ2值 | 43.773 | 16.621 | ||
P值 | 0.000 | 0.000 | ||
S100B | ||||
治疗后1周 | 5.34(2.19,10.08) | 10.15(3.63,15.72) | -3.331 | 0.047 |
治疗后2周 | 0.66(0.19,1.56) | 1.60(0.41,3.28) | -4.745 | 0.000 |
治疗后3周 | 0.40(0.11,0.74) | 0.75(0.41,1.60) | -1.207 | 0.036 |
χ2值 | 87.350 | 33.003 | ||
P值 | 0.000 | 0.000 | ||
GFAP | ||||
治疗后1周 | 45.39(10.87,84.93) | 99.75(65.79,180.84) | -4.940 | 0.000 |
治疗后2周 | 17.77(5.66,38.15) | 63.94(13.65,120.59) | -2.337 | 0.016 |
治疗后3周 | 12.82(5.04,26.90) | 38.03(10.87,85.40) | -3.745 | 0.012 |
χ2值 | 23.684 | 24.299 | ||
P值 | 0.000 | 0.000 |
[1] |
Schaaf HS, Seddon JA. Management of tuberculous meningitis in children. Paediatr Int Child Health, 2021, 41(4): 231-236. doi:10.1080/20469047.2021.1952818.
doi: 10.1080/20469047.2021.1952818 URL |
[2] |
du Preez K, Jenkins HE, Donald PR, et al. Tuberculous Meningitis in Children: A Forgotten Public Health Emergency. Front Neurol, 2022, 17(13): 751133. doi:10.3389/fneur.2022.751133.
doi: 10.3389/fneur.2022.751133 |
[3] |
Daniel BD, Grace GA, Natrajan M. Tuberculous meningitis in children: Clinical management & outcome. Indian J Med Res, 2019, 150(2): 117-130. doi:10.4103/ijmr.IJMR_786_17.
doi: 10.4103/ijmr.IJMR_786_17 URL |
[4] |
Czupryna P, Grygorczuk S, Pancewicz S, et al. Evaluation of NSE and S100B in patients with tick-borne encephalitis. Brain Behav, 2018, 8(12): e01160. doi:10.1002/brb3.1160.
doi: 10.1002/brb3.1160 |
[5] |
Zwirner J, Lier J, Franke H, et al. GFAP positivity in neurons following traumatic brain injuries. Int J Legal Med, 2021, 135(6): 2323-2333. doi:10.1007/s00414-021-02568-1.
doi: 10.1007/s00414-021-02568-1 pmid: 34114049 |
[6] |
Park DW, Park SH, Hwang SK. Serial measurement of S100B and NSE in pediatric traumatic brain injury. Childs Nerv Syst, 2019, 35(2): 343-348. doi:10.1007/s00381-018-3955-y.
doi: 10.1007/s00381-018-3955-y URL |
[7] |
Mai NT, Thwaites GE. Recent advances in the diagnosis and management of tuberculous meningitis. Curr Opin Infect Dis, 2017, 30(1): 123-128. doi:10.1097/QCO.0000000000000331.
doi: 10.1097/QCO.0000000000000331 pmid: 27798497 |
[8] | 中华人民共和国国家卫生和计划生育委员会. WS 288—2017 肺结核诊断. 2017-11-09. |
[9] |
López-Varela E, García-Basteiro AL. World Health Organization guidelines for childhood tuberculosis management: successes achieved and challenges ahead. Pediatr Infect Dis J, 2014, 33(12): 1310-1311. doi:10.1097/INF.0000000000000446.
doi: 10.1097/INF.0000000000000446 pmid: 25386971 |
[10] |
杨汝铃, 龙晓茹, 张祯祯, 等. 222例儿童结核性脑膜炎的临床特征及其预后影响因素分析. 中国防痨杂志, 2020, 42(10): 1053-1060. doi:10.3969/j.issn.1000-6621.2020.10.009.
doi: 10.3969/j.issn.1000-6621.2020.10.009 |
[11] |
Thee S, Basu Roy R, Blázquez-Gamero D, et al. Treatment and Outcome in Children With Tuberculous Meningitis: A Multicenter Pediatric Tuberculosis Network European Trials Group Study. Clin Infect Dis, 2021, 75(3): 372-381. doi:10.1093/cid/ciab982.
doi: 10.1093/cid/ciab982 URL |
[12] | World Health Organizaion. Guidance for national tuberculosis programmes on the management of tuberculosis in children. 2nd ed. Geneva: World Health Organizaion, 2014. |
[13] |
Rohlwink UK, Mauff K, Wilkinson KA, et al. Biomarkers of Cerebral Injury and Inflammation in Pediatric Tuberculous Meningitis. Clin Infect Dis, 2017, 65(8): 1298-1307. doi:10.1093/cid/cix540.
doi: 10.1093/cid/cix540 pmid: 28605426 |
[14] |
王莉, 张国军. 血清神经元特异性烯醇化酶与外伤性脑损伤患者及临床特征的关系. 首都医科大学学报, 2021, 42(5):719-720. doi:10.3969/j.issn.1006-7795.2021.05.004.
doi: 10.3969/j.issn.1006-7795.2021.05.004 |
[15] |
Arnason S, Molewijk K, Henningsson AJ, et al. Brain damage markers neuron-specific enolase (NSE) and S100B in serum in children with Lyme neuroborreliosis-detection and evaluation as prognostic biomarkers for clinical outcome. Eur J Clin Microbiol Infect Dis, 2022, 41(7): 1051-1057. doi:10.1007/s10096-022-04460-1.
doi: 10.1007/s10096-022-04460-1 URL |
[16] |
Equiza J, Rodríguez-Antigüedad J, Campo-Caballero D, et al. Autoimmune GFAP astrocytopathy presenting with remarkable CNS hyperexcitability and oculogyric crises. J Neuroimmunol, 2021, 359: 577695. doi:10.1016/j.jneuroim.2021.577695.
doi: 10.1016/j.jneuroim.2021.577695 |
[17] |
DeKosky ST, Kochanek PM, Valadka AB, et al. Blood Biomarkers for Detection of Brain Injury in COVID-19 Patients. J Neurotrauma, 2021, 38(1): 1-43. doi:10.1089/neu.2020.7332.
doi: 10.1089/neu.2020.7332 URL |
[18] |
Zurek J, Fedora M. The usefulness of S100B, NSE, GFAP, NF-H, secretagogin and Hsp 70 as a predictive biomarker of outcome in children with traumatic brain injury. Acta Neurochir (Wien), 2012, 154(1): 93-103, discussion 103. doi:10.1007/s00701-011-1175-2.
doi: 10.1007/s00701-011-1175-2 URL |
[19] |
Khandare P, Saluja A, Solanki RS, et al. Serum S100B and NSE Levels Correlate With Infarct Size and Bladder-Bowel Involvement Among Acute Ischemic Stroke Patients. J Neurosci Rural Pract, 2022, 13(2): 218-225. doi:10.1055/s-0042-1743214.
doi: 10.1055/s-0042-1743214 pmid: 35694066 |
[20] |
Rohlwink UK, Donald K, Gavine B, et al. Clinical characteri-stics and neurodevelopmental outcomes of children with tuberculous meningitis and hydrocephalus. Dev Med Child Neurol, 2016, 58(5):461-468. doi:10.1111/dmcn.13054.
doi: 10.1111/dmcn.13054 pmid: 26888419 |
[1] | National Clinical Research Centre for Infectious Disease/The Third People’s Hospital of Shenzhen, Peking University Shenzhen Hospital, Peking Union Medical College Hospital of Chinese Academy of Medical Sciences, Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis, Shenzhen Key Laboratory of Inflammatory and Immune Diseases. Expert consensus on diagnosis and treatment of latent tuberculosis infection in patients with rheumatic diseases [J]. Chinese Journal of Antituberculosis, 2022, 44(9): 869-879. |
[2] | Wang Yuxiang, Chen Qiuqi, Yu Xinxin, Zhan Senlin, Zhang Peize, Deng Guofang. 3HP regimen in the treatment of rheumatic diseases complicated with Mycobacterium tuberculosis latent infection:a prospective study [J]. Chinese Journal of Antituberculosis, 2022, 44(9): 906-910. |
[3] | Xie Jingyi, Zou Ruifeng, Chen Yulan, Chen Yong, Liu Dongzhou, Hong Xiaoping. Analysis of clinical features and peripheral lymphocyte subsets of systemic lupus erythematosus patients complicated with tuberculosis infection [J]. Chinese Journal of Antituberculosis, 2022, 44(9): 911-916. |
[4] | Cheng Xiao, Chen Zhe, Jiao Xuefeng, Yang Nan, Diao Sha, Ni Xiaofeng, Liu Zheng, He Siyi, Zeng Linan, Wan Chaomin, Kang Deying, Wu Bin, Ying Binwu, Zhang Hui, Zhao Rongsheng, Zhang Lingli. Efficacy and safety of recombinant Mycobacterium tuberculosis fusion proteins (EC) for the diagnosis of Mycobacterium tuberculosis infection: A system review [J]. Chinese Journal of Antituberculosis, 2022, 44(9): 917-926. |
[5] | Wu Wenqi, Zhong Jianqiu, He Juan, Deng Guofang, Wang Qingwen. The research progress of the reactivation of latent tuberculosis infection in patients with rheumatic diseases [J]. Chinese Journal of Antituberculosis, 2022, 44(9): 954-959. |
[6] | Dong Xiaowei, Guo Huixin, Zhang Chenchen, Wang Jiawen, He Junlei, Li Guanhai, Li Jianwei, Wen Wenpei. Application value of two-step detection of Mycobacterium tuberculosis infection screening in schools [J]. Chinese Journal of Antituberculosis, 2022, 44(8): 802-807. |
[7] | Zhao Yidi, Zhang Tongqiang, Liu Fujun, Xu Yongshen, Guo Wei. Study on the efficacy and safety of CO2 cryotherapy combined with forceps in the treatment of lymph node fistula tracheobronchial tuberculosis in infants [J]. Chinese Journal of Antituberculosis, 2022, 44(8): 827-834. |
[8] | Li Yinhong, Liu Fanglin, Lu Zhenhui, Jiang Xin. Study on the mechanism of Oridonin against pathological damage of tuberculosis [J]. Chinese Journal of Antituberculosis, 2022, 44(8): 849-854. |
[9] | XIA Hui, ZHENG Yang, SONG Yuan-yuan. Interpretation of the Optimized broth microdilution plate methodology for drug susceptibility testing of Mycobacterium tuberculosis complex issued by World Health Organization [J]. Chinese Journal of Antituberculosis, 2022, 44(7): 641-645. |
[10] | LIU Hai-ting, LI Dong-shuo, ZHANG Lei, WANG Ning, WANG Bin, DING Yang-ming, YAO Rong, LU Yu. A preliminary study on the synergy and mechanism of pyrifazimine and bedaquiline [J]. Chinese Journal of Antituberculosis, 2022, 44(7): 646-653. |
[11] | DAI Xiao-wei, WANG Nen-han, CHEN Shuang-shuang, YANG Xin-yu, TIAN Li-li, CHEN Hong, ZHANG Hong-tai, LI Chuan-you. Assessing next-generation sequencing for Mycobacterium tuberculosis diagnosis in clinical sputum samples [J]. Chinese Journal of Antituberculosis, 2022, 44(7): 669-679. |
[12] | JIA Hong-yan, DONG Jing, ZHANG Zong-de, PAN Li-ping. Progress and clinical application of immunological detection technology for Mycobacterium tuberculosis infection [J]. Chinese Journal of Antituberculosis, 2022, 44(7): 720-726. |
[13] | HE Yi-jun, CAO Xue-fang, GAO Lei. Interpretation of the Procedure of tuberculin skin test-interferon-gamma release assay two-step testing [J]. Chinese Journal of Antituberculosis, 2022, 44(5): 438-441. |
[14] | DAI Guang-ming, WANG fen, CAO Ting-ming, CHU Hong-qian, HUANG Hai-rong, SUN Zhao-gang. Study on efficiency of Mycobacterium tuberculosis detection by real-time quantitative PCR with different clinical sample types and the improvement by grinding specimen with glass beads [J]. Chinese Journal of Antituberculosis, 2022, 44(5): 450-454. |
[15] | LIANG Li, ZOU Li-ping, XIE Fang-hui, CHEN Qing, WU Gui-hui. Three cases of anti-tuberculosis therapy-associated acute liver failure in tuberculosis children and literature review [J]. Chinese Journal of Antituberculosis, 2022, 44(4): 343-348. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||